Ocera Therapeutics, Inc. (OCRX): Venrock Healthcare Capital Patners Snapping Up Shares

Page 3 of 18

Page 3 of 18 SEC Filing
CUSIP No. 67552A108
Page 3 of 18
             
  1. 
 
Name of reporting persons
 
VHCP Co-Investment Holdings, LLC
  2.
 
Check the appropriate box if a member of a group (see instructions)
(a)  x1         (b)  ¨
 
  3.
 
SEC use only
 
  4.
 
Citizenship or place of organization
 
    Delaware
Number of
shares
beneficially
owned by
each
reporting
person
with:
  
5. 
  
Sole voting power
 
    0
  
6.
  
Shared voting power
 
    1,885,6682
  
7.
  
Sole dispositive power
 
    0
  
8.
  
Shared dispositive power
 
    1,885,6682
  9.
 
Aggregate amount beneficially owned by each reporting person
 
    1,885,6682
10.
 
Check if the aggregate amount in Row (9) excludes certain shares (see instructions)    ¨
 
11.
 
Percent of class represented by amount in Row (9)
 
   9.1%3
12.
 
Type of reporting person (see instructions)
 
    OO
 
1
Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, VHCP Management, LLC, VHCP Management II, LLC, Bong Koh and Anders Hove are members of a group for the purposes of this Schedule 13G.
2
Consists of (i) 792,351 shares of common stock owned by Venrock Healthcare Capital Partners, L.P., including 118,981 shares underlying immediately exercisable warrants; (ii) 144,945 shares of common stock owned by VHCP Co-Investment Holdings, LLC, including 21,765 shares underlying immediately exercisable warrants; (iii) 674,803 shares of common stock owned by Venrock Healthcare Capital Partners II, L.P.; and (iv) 273,569 shares of common stock owned by VHCP Co-Investment Holdings II, LLC.
3
This percentage is calculated based upon 20,503,211 shares of common stock outstanding as of October 31, 2015, as set forth in Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 5, 2015.
     
 

Follow Ocera Therapeutics Inc. (NASDAQ:OCRX)

Page 3 of 18